Unichem Labs up 3% on tentative USFDA nod for Irbesartan tablets

Unichem Laboratoriessurged on Thursday after it received ANDA tentative approval from the United States Food and Drug Administration (US FDA) for Irbesartan. Final approvalwill bereceived after the patent expires on Dec. 07, 2015.

Shares ofthe companyare trading at Rs 184.70, up Rs 5.6, or 3.13% at the Bombay Stock Exchange (BSE) on Thursday at 9:33 a.m.The scrip has touched an intra-day high of Rs 186.95 and low of Rs 184. The total volume of shares traded at the BSE is 5,513.In the earlier session, the shares rose 1.19%, or Rs 2.1, at Rs 179.10. Currently, the stock is trading down 9.17% from its 52-week high of Rs 203.35 and above 82.6% over the 52-week low of Rs 101.15.

Share Price Movement Period Pricein Rs Gain/(Loss) in Rs in % 1 Week 176.90 2.20 1.24 1 Month 186.05 (6.95) (3.74) 3 Months 135.60 43.50 32.08 6 Months 147.20 31.90 21.67 1 Year 137.20 41.90 30.54 Note: Based on previous day closing price.